Elevai Labs Stock Quote ELAB - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.3179

Bid

0.2851

Ask

0.3179

Volume

319

0.00 Day's Range 0.00

0.2175 52 Week Range 4.2442

Market Cap

6.419M

Previous Close

0.292

Open

Last Trade

0.2851

Last Trade Time

05:31:48

Financial Volume

VWAP

Average Volume (3m)

2,410,924

Shares Outstanding

20,192,114

Dividend Yield

PE Ratio

-1.36

Earnings Per Share (EPS)

-0.21

Revenue

1.71M

Net Profit

-4.3M

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed... Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

elevailabs.com

Headquarters

Wilmington, Delaware, USA

Founded

Elevai Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELAB. The last closing price for Elevai Labs was $0.29. Over the last year, Elevai Labs shares have traded in a share price range of $ 0.2175 to $ 4.2442.

Elevai Labs currently has 20,192,114 shares outstanding. The market capitalization of Elevai Labs is $5.90 million. Elevai Labs has a price to earnings ratio (PE ratio) of -1.36.

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications

Case Studies Highlight Potential of Elevai Exosome Technology in Melasma Care When Used with Laser Therapy. Early Results Show Synergistic Effects of Elevai Exosomes™ and Laser Treatments for...

Form DEFR14C - Revised information statement materials, definitive

Form 8-K - Current report

Micro Cap Stealing Premarket Show Before Tuesday's Opening Bell

A California-based biotech company is turning already turning heads during Tuesday’s premarket hours after the company announced encouraging data results indicating To read the full story on...

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology

On Going Research Study Demonstrates Reversal of Hair Thinning and Inflammation with Elevai Exosomes™.Ongoing Research to Combine Exosome and Mitochondrial Technology for Enhanced Scalp and Hair...

Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™

“One of the Biggest Innovations in Hair Loss We’ve Seen in Twenty-Five Years” - BosleyMD® Teams With Start-up Yuva Biosciences in National Launch of Breakthrough Technology1Elevai Labs and Yuva...

Form 8-K - Current report

Form PRE 14C - Other preliminary information statements

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum

NEWPORT BEACH, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a pioneering force in medical aesthetics, announces the completion of a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0369	13.1316725979	0.281	0.36	0.2678	1349084	0.31309672	CS
4	-0.0271	-7.85507246377	0.345	0.39	0.2175	6983413	0.31476088	CS
12	-0.2891	-47.6276771005	0.607	0.6079	0.2175	2410924	0.31762805	CS
26	-0.4397	-58.0385427666	0.7576	0.8298	0.2175	1156383	0.34368136	CS
52	-3.6821	-92.0525	4	4.2442	0.2175	1222180	0.69606904	CS
156	-3.6821	-92.0525	4	4.2442	0.2175	1222180	0.69606904	CS
260	-3.6821	-92.0525	4	4.2442	0.2175	1222180	0.69606904	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CNEYCN Energy Group Inc	$ 0.8205 (175.15%)	25.4M
FTCIFTC Solar Inc	$ 0.418 (85.70%)	15.07M
QHQuhuo Ltd	$ 2.31 (73.68%)	5.93M
DUOFangDD Network Group Ltd	$ 0.6152 (58.23%)	5M
SXTCChina SXT Pharmaceuticals Inc	$ 0.7819 (38.56%)	5.63M
TBIOTelesis Bio Inc	$ 1.75 (-53.95%)	5.65k
VIOTViomi Technology Company Ltd	$ 1.00 (-17.36%)	4.82k
JNVRJanover Inc	$ 0.40 (-16.84%)	1
SLXNSilexion Therapeutics Corporation	$ 1.05 (-15.32%)	232.21k
DJTTrump Media and Technology Group Corporation	$ 15.93 (-14.49%)	904.82k
CNEYCN Energy Group Inc	$ 0.8205 (175.15%)	25.4M
TANHTantech Holdings Ltd	$ 0.1866 (34.83%)	21.95M
FTCIFTC Solar Inc	$ 0.418 (85.70%)	15.07M
QHQuhuo Ltd	$ 2.31 (73.68%)	5.93M
SXTCChina SXT Pharmaceuticals Inc	$ 0.7819 (38.56%)	5.63M